期刊文献+

OptiVol fluid index predicts acute decompensation of heart failure with a high rate of unexplained events 被引量:2

下载PDF
导出
摘要 Background Intrathoracic impedance monitoring has emerged as a promising new technique for the detection of impending heart failure (HF). Although false positive episodes have been reported in case reports and clinical trials, the efficacy and false positive rate in real-world practice remain unclear. Objective The aim of this study is to investigate the utility and reliability of the OptiVol alert feature in clinical practice. Methods We continuously recruited patients who underwent implantable cardioverter-defibrillator (ICD) or cardiac re-synchronization therapy with defibrillator (CRT-D) implantation with feature of intrathoracic impedance monitoring system in our center from Sep. 2010 to Oct. 2012. Regular in-office follow-up were required of all patients and the following information was collected at each visit: medical history, device interrogation, N-terminal pro-brain natriuretic peptide (NT-proBNP) measurement and an echocardiogram. Worsening HF was defined as hospitalization or the presentation of signs or symptoms of HF. Results Forty three patients (male:76.7%, mean age:57 ± 15 years, left ventricular ejection fraction (LVEF):33%± 14%) were included in this observational study. Fifty four alert events and 14 adjudicated worsening HF were detected within 288 ±163 days follow-up. Eleven (20.4%) alert episodes were associated with acute cardiac decompensation in 9 patients with a positive predictive value of 78.6%. Forty three audible alerts showed no connection to worsening HF. The unexplained alerts rate was 79.6%and 1.27 per person-year. Thirty seven alarm alerts were detected in patients with EF<45%, among which 9 accompanied with HF, 17 alerts detected in patients with LVEF≥45%and 2 associated with HF. There was no sig-nificant difference between the two groups (9/37 vs. 2/17;P=0.47). Conclusions Patients with normal or nearly normal left ventricular systolic function also exhibited considerable alert events. The OptiVol fluid index predicted worsening cardiac events with a high unex-plained detection rate, and any alert must therefore be analyzed with great caution. Efforts to improve the specificity of this monitoring sys-tem represent a significant aspect of future studies.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2013年第3期253-257,共5页 老年心脏病学杂志(英文版)
  • 相关文献

参考文献22

  • 1Roger VL,Go AS,Lloyd-Jones DM. Heart disease and stroke statistics--2012 update:a report from the American Heart Association[J].Circulation,2012.E2-E220.
  • 2Wang L,Lahtinen S,Lentz L. Feasibility of using an implantable system to measure thoracic congestion in an am-bulatory chronic heart failure canine model[J].Pacing Clin Elec-trophysiol,2005.404-411.
  • 3Ganion V,Rhodes M,Stadler RW. Intrathoracic impedance to monitor heart failure status:a comparison of two methods in a chronic heart failure dog model[J].Congestive Heart Failure,2005.177-181,211.
  • 4Becher J,Kaufmann SG,Paule S. Device-based imped-ance measurement is a useful and accurate tool for direct as-sessment of intrathoracic fluid accumulation in heart failure[J].Europace:European Pacing Arrhythmias and Cardiac Electrophysiology,2010.731-740.
  • 5Yu CM,Wang L,Chau E. Intrathoracic impedance monitoring in patients with heart failure:correlation with fluid status and feasibility of early warning preceding hospitaliza-tion[J].Circulation,2005.841-848.
  • 6Luthje L,Drescher T,Zenker D. Detection of heart fail-ure decompensation using intrathoracic impedance monitoring by a triple-chamber implantable defibrillator[J].Heart Rhythm,2005.997-999.
  • 7Small RS,Wickemeyer W,Germany R. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure:clinical utility of implanted device monitoring without a patient alert[J].Journal of Cardiac Failure,2009.475-481.
  • 8Catanzariti D,Lunati M,Landolina M. Monitoring in-trathoracic impedance with an implantable defibrillator re-duces hospitalizations in patients with heart failure[J].Pacing and Clinical Electrophysiology,2009.363-370.
  • 9Epstein AE,DiMarco JP,Ellenbogen KA. ACC/AHA/HRS,2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities[J].Heart Rhythm,2008.e1-e62.
  • 10Dickstein K,Cohen-Solal A,Filippatos G. ESC Guide-lines for the diagnosis and treatment of acute and chronic heart failure,2008:the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure,2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and en-dorsed by the European Society of Intensive Care Medicine (ESICM)[J].European Heart Journal,2008.2388-2442.

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部